Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Clean Energy Fuels Corp. (NASDAQ: CLNE) shares dropped 13.71 percent to close at $8.37 a share Friday. The stock traded between $8.27 and $9.30 on volume 7.04 million shares traded. The company reported revenues were $85.0 million for the fourth quarter of 2013, a decrease of 14.2 percent when compared to a year ago. Shares of Clean Energy Fuels are down approximately 35.0 percent year-to-date.
Get more information on Clean Energy Fuels and free access to the in-depth equity report at: www.FiveStarEquities.com/CLNE
Dril-Quip, Inc. (NYSE: DRQ) shares spiked 12.15 percent to close at $107.56 a share Friday. The stock traded between $99.07 and $110.11 on volume of 1.42 million shares traded. The company reported a net income of $47.1 million, or $1.15 per diluted share, for the fourth quarter of 2013, compared to $31.0 million, or $0.76 per diluted share, a year ago. Shares of Dril-Quip are down approximately 2.0 percent year-to-date.
Get more information on Dril-Quip and free access to the in-depth equity report at: www.FiveStarEquities.com/DRQ
Endologix, Inc. (NASDAQ: ELGX) shares fell 24.45 percent to close at $13.50 a share Friday. The stock traded between $12.86 and $13.95 on volume of 9.21 million shares traded. The company’s forecast of revenues in the range of $146.0 million to $152.0 million for fiscal 2014 fell short of estimates of $161.2 million. Shares of Endologix are down approximately 22.0 percent year-to-date.
Get more information on Endologix and free access to the in-depth equity report at: www.FiveStarEquities.com/ELGX
Endo Health Solutions Inc. (NASDAQ: ENDP) shares declined 2.05 percent to close at $79.82 a share Friday. The stock traded between $75.86 and $80.15 on volume 11.86 million shares traded. The company reported revenues were $585.0 million for the fourth quarter of 2013, down from $750.0 million a year ago. Shares of Endo Health Solutions are up approximately 18.0 percent year-to-date.
Get more information on Endo Health Solutions free access to the in-depth equity report at: www.FiveStarEquities.com/ENDP
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]